FindTrial
Sign In

Clinical randomized controlled study of IPATS technology based on mindfulness and neuromuscular activation on pelvic floor dysfunction after spinal cord injury

Clinical application of IPATS technology in pelvic floor function management of patients with spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109060
Enrollment
Unknown
Registered
2025-09-11
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

Control group:1.Health education. 2.Bladder management and defecation management 3.Intermittent catheterization and infection prevention and control 4.Emotion and compliance management
Research group:1. Breath-Pelvis Synergy Method 2. Consciousness activation training (Mindful Pelvic Activation) 3. Core-Link Integration Technique 4. Rhythmic Awakening Method 5. Dynamic scene simulat

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. All patients were over 18 years old; 2. The pelvic floor dysfunction after spinal cord injury (including urinary retention, urinary incontinence, difficulty in defecation, etc.) was definitely diagnosed, which met the Comprehensive Classification Standard of Upper/Lower Urinary Tract Dysfunction of Neurogenic Bladder Patients [6]; 3.There are different degrees of bladder function, and at least one of the following conditions exists: a. The residual urine volume of spontaneous urination exceeds 100ml;; B. urinary incontinence; C. urinary retention; 4. Patients have informed consent and are willing to cooperate.

Exclusion criteria

Exclusion criteria: 1. Patients with severe acid-base imbalance, water-electrolyte disorder, and severe impairment of heart, lung and other organs; 2. Patients with severe urinary system infection, coagulopathy and infectious diseases; 3. Patients with severe heart, liver and kidney diseases, anterior urethral sphincterotomy, cystostomy and other major surgical treatments of urinary system in the past; 4. safe bladder capacity < <100ml, bladder perforation; 5. Patients with frequent autonomic hyperreflexia (AD), bladder pressure higher than 40cmH2O for a long time, and bladder-ureter reflux; 6. People with consciousness disorder and mental illness [8]; 7. The condition is unstable; 8. A lot of fluid replacement; 9. Unwilling to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Pelvic floor muscle strength;Autonomic urination ability;Stool control ability;Quality of life influence;Compliance and satisfaction;—

Countries

China

Contacts

Public ContactYang Yue

West China Hospital, Sichuan University

m15982249923@163.com+86 159 8224 9923

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026